The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESMO 2023 | Challenges in managing SCLC
Antonio Calles Blanco, MD, Gregorio Maranon General University Hospital, Madrid, Spain, shares challenges in the management of small cell lung cancer (SCLC), including associated comorbidities, and high attrition rates between first- and second-line treatment. This interview took place at the European Society for Medical Oncology (ESMO) 2023 Congress in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
